AlenMed

Treatment in Germany

EN

Mon–Fri 9:00–21:00 · Sat 10:00–18:00 (CET)
+49 176 61975550 — daily until 23:00

Thrombocytopenia treatment in Germany

Updated

It usually starts with a blood test: the platelet line shows a figure below the reference range while the person feels perfectly well. Then come either steroids straight away or an offer to «keep an eye on it», and the patient is left feeling that nobody looked for the cause. Looking for the cause is exactly what people travel to Germany for.

Thrombocytopenia treatment in Germany starts with finding out why the platelet count is low. This page covers how German hospitals find the answer, when treatment is needed and when not, and how the trip is organised. Other blood conditions are on the page about blood disease treatment in Germany.

Why the platelet count falls

Platelets are the blood cells that stop bleeding, and a low count can mean three different things: too few are being made, they are being destroyed too fast, or they have pooled in an enlarged spleen. Everything in the treatment follows from which of the three it is.

The main causes are immune thrombocytopenia, where the body destroys its own platelets; a reaction to a medicine; viral infections; liver disease with an enlarged spleen; bone marrow disorders; vitamin B12 and folate deficiency; and pregnancy. A false low count is a separate case: platelets clump in the tube with the anticoagulant and the analyser misses them, so the test is repeated in a different tube, for example one with citrate.

Some situations are a matter of hours, and travel is the wrong plan: heavy bleeding, blood in the urine or stool, widespread bruising with a very low count, or a severely unwell patient whose platelets and haemoglobin are falling together. These call for emergency admission locally, not for planning a trip.

How the cause is looked for in Germany

In Germany the search starts with a repeat count, and a doctor examines the blood film under the microscope instead of relying on the analyser alone. The film often answers the question before any complex test does.

Next come liver function tests and an ultrasound of the spleen, tests for viral infections, thyroid and autoimmune markers, vitamin levels and a review of every drug the patient takes. If the picture stays unclear or a marrow disorder is suspected, the bone marrow itself is examined. Crucially, immune thrombocytopenia is a diagnosis of exclusion, made once the other causes have been checked and ruled out, as the German Society for Haematology and Medical Oncology (DGHO) guideline on immune thrombocytopenia (in German) also states.

Patients bring a series of counts over time rather than a single result, a full list of current medicines, including over-the-counter and herbal products, and discharge summaries. The trend over recent months is sometimes more informative than the newest figure, because it shows whether the count is falling or stable. Part of the testing is repeated on site, which is routine.

What the treatment consists of

Treatment combines monitoring, drugs and work on the underlying disease, and it targets the risk of bleeding, not the number. With a moderately reduced count and no bleeding, watchful monitoring with repeat tests is a legitimate decision rather than a refusal to treat.

In immune thrombocytopenia a short course of steroids usually comes first. If the count must rise quickly, intravenous immunoglobulin is given. Next come drugs that stimulate platelet production in the marrow, the thrombopoietin receptor agonists, and other immune-directed drugs if those fail. Removal of the spleen is now discussed less often and later than it used to be.

For other causes, the cause itself is treated: the culprit drug is stopped or swapped, the liver disease or infection is treated, and deficiencies are corrected. In marrow disorders treatment follows the primary diagnosis; these are covered on the pages about haematological oncology in Germany and blood cancer treatment in Germany.

Who looks after a patient like this

A haematologist working with the laboratory looks after such a patient, and secondary causes, where another disease lowers the count, bring in a gastroenterologist, an infectious diseases specialist or a rheumatologist. The haematologists AlenMed works with include Prof. Tobias Herold, head of haematology, oncology, stem cell transplantation and palliative medicine at München Klinik Bogenhausen, and Dr Fariborz Abedinpour, head of the haematology and oncology department at the Josephinum clinic in Munich. In Stuttgart there is Prof. Jochen Greiner, medical director for internal medicine and head of haematology and oncology, stem cell transplantation and palliative medicine at the Diakonie-Klinikum.

With this condition a second opinion most often changes the diagnosis rather than the drug, because a cause nobody had checked turns up. The general work-up is described on the page about diagnostics in Germany.

Frequently asked questions

Does thrombocytopenia always need treatment?

No, not always. With a moderately reduced count and no bleeding, the haematologist may suggest monitoring with repeat blood tests. The decision to treat rests above all on the risk of bleeding, not on one figure, and a clear cause, such as a medicine or a vitamin deficiency, is dealt with first.

Can immune thrombocytopenia be cured?

In some patients it can: after treatment a lasting remission sets in and no further drugs are needed. In others the disease becomes chronic, and the aim is then not a normal figure but freedom from bleeding and a good quality of life, even with a count below the reference range.

How long does the work-up for thrombocytopenia take in Germany?

Usually several days, often as an outpatient without a hospital stay. The hospital gives the actual timings after the haematologist has reviewed the counts and reports, since they determine which tests are needed. The bone marrow is examined only if the picture stays unclear or a marrow disorder is suspected.

How AlenMed arranges the treatment

AlenMed sends the series of counts, the medication list and the discharge summaries to the haematology department of a partner hospital. The company works with 86 partner hospitals in 38 cities in Germany and 345 doctors, and its office is in Munich. The paperwork covers a translated discharge summary, the hospital’s written reply, the invitation letter and the medical visa; an interpreter attends the appointment. The work-up usually takes several days, often as an outpatient, but the hospital states the actual timings.

Ask in advance what the estimate covers, who will monitor the counts after the return home and how often, what to do if the count drops, and which documents you take home.

This material is for information only and is not an offer. The treatment plan is decided by a doctor at an in-person consultation.